These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14977213)

  • 1. Neuroprotection: a realistic goal for aged brain?
    Calzà L; Giardino L
    Adv Exp Med Biol; 2004; 541():153-68. PubMed ID: 14977213
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasticity of GABA(a) system during ageing: focus on vestibular compensation and possible pharmacological intervention.
    Giardino L; Zanni M; Fernandez M; Battaglia A; Pignataro O; Calzà L
    Brain Res; 2002 Mar; 929(1):76-86. PubMed ID: 11852033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia medications in palliative care #174.
    Morrison LJ; Liao S
    J Palliat Med; 2008 May; 11(4):634-5. PubMed ID: 18454618
    [No Abstract]   [Full Text] [Related]  

  • 4. Ca2+-permeable non-NMDA glutamate receptors in rat magnocellular basal forebrain neurones.
    Waters DJ; Allen TG
    J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):453-69. PubMed ID: 9508809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
    Fariello RG
    Funct Neurol; 1997; 12(3-4):221-5. PubMed ID: 9218984
    [No Abstract]   [Full Text] [Related]  

  • 6. Nicergoline increases serum substance P levels in patients with an ischaemic stroke.
    Nishiyama Y; Abe A; Ueda M; Katsura K; Katayama Y
    Cerebrovasc Dis; 2010 Jan; 29(2):194-8. PubMed ID: 20029189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic potential and possibilities of using of sermion (nicergoline) in neurological practice].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):119-22. PubMed ID: 21434467
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulindac improves memory and increases NMDA receptor subunits in aged Fischer 344 rats.
    Mesches MH; Gemma C; Veng LM; Allgeier C; Young DA; Browning MD; Bickford PC
    Neurobiol Aging; 2004 Mar; 25(3):315-24. PubMed ID: 15123337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
    Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
    Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of isoflurane and N-methyl-D-aspartate receptors in ischemic brain injury.
    Tsuda K
    Stroke; 2010 Oct; 41(10):e578; author reply e579. PubMed ID: 20813996
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complex application 2-ethyl-6-methyl-3-hydroxypyridine-succinate and vinpocetine in cerebrovascular disorder.].
    Solovyeva EY; Karneev AN; Chekanov AV; Baranova OA; Choi IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):103-108. PubMed ID: 28638040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated injections of nicergoline increase the nerve growth factor level in the aged rat brain.
    Nishio T; Sunohara N; Furukawa S; Akiguchi I; Kudo Y
    Jpn J Pharmacol; 1998 Mar; 76(3):321-3. PubMed ID: 9593228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection and recovery: recent data at the bench on citicoline.
    Hurtado O; Lizasoain I; Moro MÁ
    Stroke; 2011 Jan; 42(1 Suppl):S33-5. PubMed ID: 21164125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of troxerutin protects mouse brain against D-galactose-induced impairment of cholinergic system.
    Lu J; Wu DM; Hu B; Cheng W; Zheng YL; Zhang ZF; Ye Q; Fan SH; Shan Q; Wang YJ
    Neurobiol Learn Mem; 2010 Feb; 93(2):157-64. PubMed ID: 19766199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
    Frölich L; Schmitt B; Calabrese P; Diener H; Förstl H; Gertz HJ; Hallauer JF; Hampel H; Ihl R; Rieke K; Riepe M; Supprian T
    Dtsch Med Wochenschr; 2005 Feb; 130(8):408-12. PubMed ID: 15717252
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ibuprofen on cognition and NMDA receptor subunit expression across aging.
    Márquez Loza A; Elias V; Wong CP; Ho E; Bermudez M; Magnusson KR
    Neuroscience; 2017 Mar; 344():276-292. PubMed ID: 28057539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
    Alam M; Danysz W; Schmidt WJ; Dekundy A
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):198-207. PubMed ID: 19616571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2 receptor-dependent modulation of striatal NO synthase activity.
    Sammut S; Bray KE; West AR
    Psychopharmacology (Berl); 2007 Apr; 191(3):793-803. PubMed ID: 17206493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine.
    Stadler H; Lloyd KG; Gadea-Ciria M; Bartholini G
    Brain Res; 1973 Jun; 55(2):476-80. PubMed ID: 4351628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.